FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology and molecular biology. Disclosed are a recombinant virus of Marek serotype 1 (rMDV1) disease for treating birds, containing in its genome a foreign gene in which said foreign gene is located in untranslated genomic region of genome, and wherein the untranslated genetic segment is located in the genome between MDV010 and MDV011, between MDV015.5 and MDV016, between MDV033 and MDV034, between MDV071 and MDV072 or between MDV096 and MDV097.6, as well as a nucleic acid molecule, a host cell, a method for producing or reproducing rMDV1, a composition, a vaccine, the use of rMDV1 and a kit for vaccination.
EFFECT: invention can be used for vaccination of poultry against avian pathogens.
19 cl, 9 dwg, 1 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT MAREK'S DISEASE VIRUSES AND USES THEREOF | 2014 |
|
RU2681889C2 |
| DUCK ENTERITIS VIRUS AND USE THEREOF | 2016 |
|
RU2721575C2 |
| DUCK ENTERITIS VIRUS AND ITS APPLICATION | 2017 |
|
RU2771165C2 |
| MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNISING AVIAN SPECIES | 2013 |
|
RU2658439C2 |
| MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNISATION OF BIRDS | 2013 |
|
RU2766003C2 |
| RECOMBINANT AVIAN HERPES VIRUSES CONTAINING SEVERAL ALIEN GENES | 2019 |
|
RU2812979C2 |
| RECOMBINANT NONPATHOGENIC MDV VECTOR PROVIDING POLY-SPECIFIC IMMUNITY | 2012 |
|
RU2593950C2 |
| RECOMBINANT NON-PATHOGENIC STRUCTURES OF MAREK'S DISEASE VIRUS, ENCODING ANTIGENS OF INFECTIOUS LARYNGOTRACHEITIS VIRUS AND INFECTIOUS BURSITIS VIRUS | 2017 |
|
RU2777400C2 |
| IMPROVED ND-IBD VACCINE BASED ON HVT VECTOR | 2015 |
|
RU2692013C2 |
| RECOMBINANT HVT VECTORS EXPRESSING BIRD PATHOGENS ANTIGENS AND THEIR APPLICATION | 2012 |
|
RU2620936C2 |
